Search alternatives:
significant case » significant cause (Expand Search), significant based (Expand Search), significant change (Expand Search)
larger decrease » marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
case based » made based (Expand Search), game based (Expand Search), rate based (Expand Search)
Showing 21 - 40 results of 19,393 for search '(( significant case based ) OR ( significantly ((teer decrease) OR (larger decrease)) ))', query time: 0.92s Refine Results
  1. 21
    Significant genes identified in the gene-based test with GWAS summary data.

    Significant genes identified in the gene-based test with GWAS summary data. by Samantha Gonzales (8798435)

    Published 2025
    Save to List
    Saved in:
  2. 22
    Phase 2 significant effects.

    Phase 2 significant effects. by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  3. 23
    Phase 1 significant effects.

    Phase 1 significant effects. by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  4. 24
    CBP per cumulative year for daratumumab and pembrolizumab per vial.

    CBP per cumulative year for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 25
    S4 Fig -

    S4 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 26
    S1 Fig -

    S1 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 27
    S5 Fig -

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 28
    S3 Fig -

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 29
    S6 Fig -

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 30
    CBP per cumulative indication for daratumumab and pembrolizumab per vial.

    CBP per cumulative indication for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 31
    S2 Fig -

    S2 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 32
    S1 Data -

    S1 Data - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 33
    Pairs of clusters that were significantly different from each other based on the layer profile of their cases.

    Pairs of clusters that were significantly different from each other based on the layer profile of their cases. by Lauren S. Richardson (16841643)

    Published 2024
    “…<p>Pairs of clusters that were significantly different from each other based on the layer profile of their cases.…”
    Save to List
    Saved in:
  14. 34
    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells.

    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

    Published 2024
    Save to List
    Saved in:
  15. 35
    Base-case results.

    Base-case results. by Parima Hirunwiwatkul (14797370)

    Published 2025
    Save to List
    Saved in:
  16. 36
    T-test statistical significance results.

    T-test statistical significance results. by Ahmed Hamza Osman (10189569)

    Published 2021
    Save to List
    Saved in:
  17. 37
    Base case regression results.

    Base case regression results. by Florian Hofer (7377338)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 38
    Base-case results.

    Base-case results. by Unchalee Permsuwan (5478434)

    Published 2024
    Save to List
    Saved in:
  19. 39
    GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model.

    GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

    Published 2023
    Save to List
    Saved in:
  20. 40
    The results of KEGG enrichment analysis (Annotation: Circles represent each pathway, and the redder the color, the larger the circle, and the more important it is).

    The results of KEGG enrichment analysis (Annotation: Circles represent each pathway, and the redder the color, the larger the circle, and the more important it is). by Lin Zhou (141050)

    Published 2023
    Save to List
    Saved in:

Search Tools: